The FLF at the ASH 2024 Annual Meeting: Advancing Follicular Lymphoma Research
The Follicular Lymphoma Foundation (FLF) is dedicated to ensuring that patient needs are central to the future of follicular lymphoma research. By attending the American Society of Hematology (ASH) Annual Meeting each year, the FLF amplifies the urgency of follicular lymphoma on a global stage, forging collaborations with leading scientists and pharmaceutical partners to accelerate the development of innovative treatments. Our dedicated mission is to drive the pathway toward a cure.
Why we attend the ASH Annual Meeting
At the FLF, it is our heartfelt belief that patients must remain central to all discussions about follicular lymphoma. By participating in the ASH Annual Meeting, we ensure that the voices and needs of patients are included in the conversations shaping the future of follicular lymphoma research. Our presence allows us to play a key role in influencing the direction of research, working alongside major partners to advance treatment developments. Each year, we gather insights, share knowledge, and cultivate relationships that propel follicular lymphoma research forward.
Our key objectives
One of the FLF’s primary goals is to amplify awareness of follicular lymphoma. We bring this message to a global audience of scientists and pharmaceutical companies at ASH, highlighting the urgency of focusing on this disease within research agendas. Crucially, face-to-face meetings at the conference provide an opportunity to deepen our partnerships with top scientists and industry stakeholders. These collaborations are vital to the progress of research initiatives such as our CURE FL program and Biomarker Discovery Program.
Attending ASH keeps us at the cutting edge of scientific discoveries in the field. We continuously seek out new research opportunities, learning from the latest developments to accelerate the delivery of more effective treatments for patients. By staying at the forefront of innovation, we ensure that follicular lymphoma research evolves to meet patient needs more quickly and effectively.
The FLF’s contributions at ASH
Each year at ASH, the FLF plays an active role in sharing research and patient feedback, providing updates on key research initiatives such as our Biomarker Discovery Program, and engaging in discussions on breakthrough treatments, including immunotherapy and other advanced therapies. Our presence at the conference fosters collaboration with experts in hematology and oncology worldwide, advancing the search for new treatment pathways.
Looking ahead
The FLF is dedicated to shaping the future of follicular lymphoma research. Our annual participation in the ASH Annual Meeting, enables us to influence the direction of research and treatment strategies, always keeping patients at the heart of our mission.
Stay connected with the FLF to keep up to date with the latest developments in hematology and our ongoing efforts to unlock a cure for follicular lymphoma. Sign up to our newsletter here: Newsletter signup form.